Xue Mei M - OmicsDI

Show results for

Unknown (61)
Metabolomics (10)
Transcriptomics (8)
Genomics (7)
Proteomics (7)

Organisms

Homo sapiens (14)
Archaea (5)
Bacteria (5)
Betaherpesvirinae (5)
Borrelia (5)
Botrytis cinerea (5)
Candida albicans (5)
Clostridium perfringens (5)
Eukaryota (5)
Fungi (5)
Hepatitis B virus (5)
Herpesvirales (5)
Human betaherpesvirus 5 (5)
Influenza C virus (5)
Japanese encephalitis virus group (5)
Miscanthus x giganteus (5)
Mycobacterium tuberculosis (5)
Orthoflavivirus (5)
Panicum virgatum (5)
Rattus (5)
Saccharomyces cerevisiae (5)
Salmonella enterica subsp. enterica (5)
Schizosaccharomyces (5)
Schizosaccharomyces pombe (5)
Severe acute respiratory syndrome coronavirus 2 (5)
Staphylococcus aureus (5)
Streptococcus pneumoniae (5)
Toxoplasma gondii (5)
Drosophila melanogaster (2)
Bos taurus (1)

Repository

MetaboLights (10)
biostudies-arrayexpress (9)
EGA (6)
pride (5)
iProX (2)

Tissue

Blood cell (2)
Cell culture (1)
Lung (1)
Permanent cell line cell (1)

Disease

Acute leukemia (2)
Lymphoma (1)

Technology Type

Mass spectrometry (8)
Mass Spectrometry (5)
Top-down proteomics (2)
NMR spectroscopy (1)
Mass spectrometry assay (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (3)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS - negative - reverse phase (2)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
Wates I-Class/XEVO-G2 XS QTOF (1)
Agilent 7890 (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Bruker (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2026 (3)
2024 (3)
2019 (3)
2022 (2)
2020 (2)
2011 (2)
2010 (2)
2008 (2)
2018 (2)
2014 (1)
2023 (1)
2021 (1)
2017 (1)
2025 (1)

CHEBI ID

CHEBI:15741 (4)
CHEBI:17154 (4)
CHEBI:16335 (4)
CHEBI:15843 (4)
CHEBI:16704 (4)
CHEBI:30915 (4)
CHEBI:74168 (3)
CHEBI:16070 (3)
CHEBI:16217 (3)
CHEBI:17553 (3)
CHEBI:25094 (3)
CHEBI:17858 (3)
CHEBI:16811 (3)
CHEBI:28300 (3)
CHEBI:16708 (3)
CHEBI:15887 (3)
CHEBI:17361 (3)
CHEBI:24898 (3)
CHEBI:15551 (3)
CHEBI:15428 (3)
CHEBI:16610 (3)
CHEBI:16634 (3)
CHEBI:1879 (3)
CHEBI:37024 (3)
CHEBI:116314 (3)
CHEBI:16235 (3)
CHEBI:17650 (3)
CHEBI:17509 (3)
CHEBI:18300 (3)
CHEBI:55328 (3)

Metabolite Name

Quinoline-4-carboxylic acid (2)
Galactitol (2)
Trigonelline (2)
Thiamine (2)
Loganin (2)
Pyridoxine (2)
Arachidonic acid (2)
Adenosine (2)
Guanine (2)
Adenine (2)
Gluconolactone (2)
Inosine (2)
(+)-(s)-carvone (1)
6-[(3e,5e,7s)-5,7-dimethyl-2-oxo-3,5-nonadien-1-yl]-2,4-dihydroxy-3-methylbenzaldehyde (1)
(3ar,4s,6r,11ar)-6,9-dihydroxy-6,10-dimethyl-3-methylene-2,7-dioxo-2,3,3a,4,5,6,7,8,9,11a-decahydrocyclodeca[b]furan-4-yl methacrylate (1)
Dipropyl adipate (1)
Isochlorogenic acid c (1)
Al 8810 methyl ester (1)
(8e)-11,13-dihydroxy-4-methyl-4,5,6,7-tetrahydro-2h-3-benzoxacyclododecine-2,10(1h)-dione (1)
(+)-ar-turmerone (1)
Isorhamnetin-3-o-nehesperidine (1)
Glycerol tributyrate (1)
(+)-catechin (hydrate) (1)
R-1 methanandamide phosphate (1)
(1r,9r)-5-cyclohexyl-11-(propylsulfonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one (1)
(-)-a-pinene (1)
3',5,7-trihydroxy-4'-methoxyflavanone (1)
Kaempferol-3-o-rutinoside (1)
Methyl 4-[(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxo-1-cyclohexen-1-yl)oxy]-2-hydroxy-3,6-dimethylbenzoate (1)
1,9b-dihydroxy-6,6,9a-trimethyl-5,5a,6,7,8,9,9a,9b-octahydronaphtho[1,2-c]furan-3(1h)-one (1)

Study type

RNA-seq of coding RNA (3)
Transcription profiling by array (2)
Cell line - Single-cell sequencing (1)
ChIP-chip by tiling array (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2024 (14)
2025 (12)
2022 (7)
2014 (5)
2023 (4)
2021 (4)
2019 (4)
2016 (4)
2017 (3)
2020 (2)
2011 (2)
2010 (2)
2008 (2)
2026 (2)
2018 (1)
2015 (1)
2013 (1)

Lab affiliation

Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China (2)
Department of Medicine & Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, P. R. China, 264003 (1)
School of Life Sciences and Technology, Tongji University (1)
Zhengzhou University (1)

Previous page
1 / 10
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 10
Next page

Sort by:

Relevance

Page size

Multi-omics integration reveals Yu-Xue-Bi tablets attenuate rheumatoid arthritis via metabolic reprogramming-mediated Piezo1 suppression

As a systemic chronic inflammatory disease, Rheumatoid arthritis (RA) is characterized by progressive inflammation, bone and cartilage destruction, leading to significant disability, reduced lifespan, and increased mortality. The clinical use of conventional medications including nonsteroidal ant...

2026-01-24 | MTBLS13760 | MetaboLights

Effect Western Medicines Combined With Nao-Xue-Shu in Patients With Hypertensive Intracerebral Hemorrhage: A Network Meta-Analysis.

Not available

S-EPMC9240398 | biostudies-literature

Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.

Not available

S-EPMC4112873 | biostudies-literature

Metabolomics analyses of cancer tissue from patients with colorectal cancer.

The alteration of metabolism is essential for the initiation and progression of numerous types of cancer, including colorectal cancer (CRC). Metabolomics has been used to study CRC. At present, the reprogramming of the metabolism in CRC remains to be fully elucidated. In the present study, comprehen...

2024-02-08 | MTBLS8090 | MetaboLights

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report.

Not available

S-EPMC9032064 | biostudies-literature

Design and statistical analysis reporting among interrupted time series studies in drug utilization research: a cross-sectional survey.

Not available

S-EPMC10924989 | biostudies-literature

Sulfadiazine Sodium Improves Dysfunctional Metabolomics in Toxoplasma gondii-infected Mice

Toxoplasma gondii is an obligate intracellular protozoan parasite that poses a severe threat to human health, especially those immune-compromised individuals. Sulfadiazine sodium (SDZ) is widely used for the treatment of human toxoplasmosis. However, systems biology researches on the therapeutic eff...

2019-06-18 | MTBLS852 | MetaboLights

Integrating randomized controlled trials and non-randomized studies of interventions to assess the effect of rare events: a Bayesian re-analysis of two meta-analyses.

Not available

S-EPMC11430109 | biostudies-literature

SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy.

Not available

S-EPMC8263595 | biostudies-literature

Identification of DDR1-interacting proteins by IP-MS screening

To investigate and identify the potential DUBs that stabilize and interact with DDR1, we performed immunoprecipitation of endogenous DDR1 with anti-DDR1 antibody (specific IP) or anti-IgG antibody (negative control) in A549 cells followed by mass spectrometry analysis.

ORGANISM(S): Homo sapiens (Human)

2025-09-08 | PXD065332 | Pride

Previous page
1 / 10
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 10
Next page

Sort by:

Relevance

Page size

93 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets